Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIAP.L Regulatory News (IAP)

  • There is currently no data for IAP

Director/PDMR Shareholding

20 May 2009 18:28

RNS Number : 6120S
ICAP PLC
20 May 2009
 



ICAP plc Announcement

 

1. ICAP plc has received the following statement from IPGL Limited (IPGL).

"On 19 May 2009 IPGL's subsidiary company INCAP Finance B.V. sold 12,700,000 of the 130,769,560 ICAP plc ordinary shares it owns at a price of £3.90 per share. IPGL has been very successful in reducing the leverage on its balance sheet during the past year. The proceeds from the sale of these ICAP plc shares will be used as part of the further deleveraging of the IPGL business. IPGL does not plan to sell any further ICAP plc shares in the foreseeable future."

Michael Spencer, the founder and chief executive of ICAP plc, together with his wife and family trusts, are majority shareholders of IPGL Limited.

2. On 19 May 2009, Michael Spencer exercised 5,608,248 options under the ICAP 2003 Bonus Share Matching Plan. These options were awarded to Michael Spencer on 16 July 2003, 4 June 2004, 10 June 2005 and 22 June 2006 at a total exercise price of £8.00.

In order to meet the tax liability which is incurred immediately on the exercise of those options, Michael Spencer sold on the London Stock Exchange on 19 May 2009 a total of 2,300,000 shares at a price of £3.90 per share.

Following these transactions, Michael Spencer had a personal interest in 5,533,235 ICAP plc ordinary shares and through IPGL he had a further interest in 118,069,560 ordinary shares. Together these represent 19.0% of ICAP plc's share capital.

 

Contacts:

Mike Sheard

Director of Corporate Affairs

+44 (0) 20 7050 7103

Neil Bennett

Maitland

+44 (0) 20 7379 5151

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, equities and equity derivatives through voice and electronic networks. ICAP has an average daily transaction volume in excess of $2.3 trillion, more than 40% of which is electronic. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com

About IPGL

IPGL Limited is a private holding company which focuses on partnering with experienced management teams to build fast growing businesses in financial services and other sectors where we can use the group's deep sector expertise and entrepreneurial skills of the investment team to increase the probability of success and accelerate each company's growth. Our interest is in developing young businesses into industry leaders over the long term. The value we create is then invested into new opportunities. Over the past 20 years the group has had considerable success in building broking, retail CFD, fund management, insurance and gaming companies.

At the moment, the group has large minority or majority holdings in over 15 public and private trading companies ICAP plc, the FTSE 100 listed interdealer broker and a majority holding of City Index, a leading provider of CFD and spread betting services. In addition to the principal activity of being a long term investor in businesses, the group is a successful trader in alternative assets such as wine, art and property. More information can be found at: www.ipgl.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSILFFDESIIFIA
Date   Source Headline
20th May 20106:00 pmRNSTransaction in Own Shares
19th May 20106:00 pmRNSDirector/PDMR Shareholding
19th May 20107:00 amRNSFinal Results
4th May 20105:01 pmRNSTotal Voting Rights
1st Apr 20101:34 pmRNSDirectorate Change
1st Apr 20101:09 pmRNSTotal Voting Rights
25th Mar 20105:00 pmRNSDirector/PDMR Shareholding
24th Mar 20107:00 amRNSTrading Statement
22nd Mar 20107:00 amRNSStatement re review of cash equities businesses
18th Mar 201010:01 amRNSHolding(s) in Company
18th Mar 20109:46 amRNSUpdate re acquisition of TriOptima
1st Mar 201011:19 amRNSTotal Voting Rights
15th Feb 20109:30 amRNSBlocklisting Interim Review
15th Feb 20109:30 amRNSBlocklisting Interim Review
15th Feb 20109:30 amRNSBlocklisting Interim Review
15th Feb 20107:00 amRNSStatement re. Press Comment
9th Feb 201012:30 pmRNSDirector/PDMR Shareholding
8th Feb 20105:14 pmRNSHolding(s) in Company
5th Feb 20107:00 amRNSInterim Management Statement
1st Feb 201011:22 amRNSTotal Voting Rights
1st Feb 201010:04 amRNSScrip Dividend Scheme
27th Jan 20105:51 pmRNSDirector/PDMR Shareholding
13th Jan 20106:16 pmRNSScrip Dividend Scheme
11th Jan 20104:43 pmRNSDirector/PDMR Shareholding
4th Jan 20103:28 pmRNSTotal Voting Rights
18th Dec 20095:42 pmRNSStatement Re Settlement with SEC
7th Dec 200912:00 pmRNSHolding(s) in Company
1st Dec 20094:38 pmRNSTotal Voting Rights
23rd Nov 200910:58 amRNSDirectorate Change
20th Nov 20094:44 pmRNSDirector/PDMR Shareholding
17th Nov 20097:00 amRNSInterim results
2nd Nov 200912:30 pmRNSTotal Voting Rights
23rd Oct 20094:46 pmRNSFormal notice
15th Oct 200910:30 amRNSHolding(s) in Company
6th Oct 200912:00 pmRNSHolding(s) in Company
2nd Oct 200910:00 amRNSHolding(s) in Company
1st Oct 20099:00 amRNSTotal Voting Rights
1st Oct 20097:00 amRNSTrading Statement
28th Sep 20091:20 pmRNSHolding(s) in Company
21st Sep 20092:08 pmRNSDirector/PDMR Shareholding
21st Sep 20092:05 pmRNSDirector/PDMR Shareholding
18th Sep 20095:23 pmRNSHolding(s) in Company
18th Sep 200910:17 amRNSDirectorate Change
11th Sep 20095:02 pmRNSHolding(s) in Company
1st Sep 200911:45 amRNSTotal Voting Rights
21st Aug 20097:00 amRNSBlocklisting
20th Aug 20097:00 amRNSAdditional Listing
14th Aug 20093:10 pmRNSBlocklisting Interim Review
14th Aug 20093:10 pmRNSBlocklisting Interim Review
14th Aug 20093:10 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.